Factor V Leiden and pulmonary embolism in a young woman taking an oral contraceptive

被引:6
作者
DiSiena, MR [1 ]
Intres, R [1 ]
Carter, DJ [1 ]
机构
[1] Berkshire Med Ctr, Dept Pathol, Pittsfield, MA 01201 USA
关键词
venous thromboembolus; pulmonary emboli; activated protein C; factor C Leiden; oral contraceptive;
D O I
10.1097/00000433-199812000-00013
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
A 34-year-old woman with a history of asthma and oral contraceptive use died suddenly. Autopsy examination showed chronic pulmonary emboli with an acute pulmonary saddle embolus. An underlying congenital thrombophilic disorder was considered. Molecular studies on DNA isolated from blood using polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) analysis revealed coagulation factor V Leiden mutation. The incidence of venous thromboembolism in patients with factor V Leiden mutation and associated activated protein C (APC) resistance is discussed.
引用
收藏
页码:362 / 367
页数:6
相关论文
共 26 条
[21]   INCREASED RISK OF VENOUS THROMBOSIS IN ORAL-CONTRACEPTIVE USERS WHO ARE CARRIERS OF FACTOR-V LEIDEN MUTATION [J].
VANDENBROUCKE, JP ;
KOSTER, T ;
BRIET, E ;
REITSMA, PH ;
BERTINA, RM ;
ROSENDAAL, FR .
LANCET, 1994, 344 (8935) :1453-1457
[22]   Third-generation oral contraceptive and deep venous thrombosis: From epidemiologic controversy to new insight in coagulation [J].
Vandenbroucke, JP ;
Helmerhorst, FM ;
Bloemenkamp, KWM ;
Rosendaal, FR .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1997, 177 (04) :887-891
[23]   BLEEDING COMPLICATIONS IN ORAL ANTICOAGULANT-THERAPY - AN ANALYSIS OF RISK-FACTORS [J].
VANDERMEER, FJM ;
ROSENDAAL, FR ;
VANDENBROUCKE, JP ;
BRIET, E .
ARCHIVES OF INTERNAL MEDICINE, 1993, 153 (13) :1557-1562
[24]   ASSOCIATION OF IDIOPATHIC VENOUS THROMBOEMBOLISM WITH SINGLE POINT-MUTATION AT ARG(506) OF FACTOR-V [J].
VOORBERG, J ;
ROELSE, J ;
KOOPMAN, R ;
BULLER, H ;
BERENDS, F ;
TENCATE, JW ;
MERTENS, K ;
VANMOURIK, JA .
LANCET, 1994, 343 (8912) :1535-1536
[25]   Factor V Cambridge:: A new mutation (Arg306→Thr) associated with resistance to activated protein C [J].
Williamson, D ;
Brown, K ;
Luddington, R ;
Baglin, C ;
Baglin, T .
BLOOD, 1998, 91 (04) :1140-1144
[26]   LINKAGE BETWEEN INHERITED RESISTANCE TO ACTIVATED PROTEIN-C AND FACTOR-V GENE MUTATION IN VENOUS THROMBOSIS [J].
ZOLLER, B ;
DAHLBACK, B .
LANCET, 1994, 343 (8912) :1536-1538